Follow the Better Therapeutics (NASDAQ:BTTX) Insiders?

Follow the Better Therapeutics (NASDAQ:BTTX) Insiders?

Better Therapeutics, Inc. (NASDAQ:BTTX) is up nearly 40% in premarket trading this morning. While it’s still just in the $1.25 range, so it’s well below most fund’s low price threshold, this is one that risk inclined investors should keep an eye on.

Better Therapeutics’ insiders, from officers to directors, have reportedly purchased over 12 million shares to zero sales over the past 12 months (https://www.nasdaq.com/market-activity/stocks/bttx/insider-activity). Better Therapeutics insiders now own more than half of the company and, if the $10 buys are any indication, BTTX could have significant upside potential.

JOIN OUR NEWSLETTER

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist